Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.

Quotes for Hamlet Pharma AB

Right Now

+/-
-0.06
%
-1,67%
Latest
3.54
High
3.685
Low
3.465
Volume
13 083
Turnover (SEK)
46 193
Market Value (MSEK)
391,3
Time (Latest trade)

Board

CEO

  • Martin Erixon

Chairperson of the Board

  • Catharina Svanborg

Board

  • Bengt Westermark
  • Bill Hansson
  • Helena Lomberg
  • Lars Hedbys
  • Ulla Trädgårdh

Videos

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 49,33 83,49 2022-12-28
Nordnet Pensionsförsäkring 4,95 1,20 2022-12-28
Avanza Pension 4,69 1,21 2022-12-28
Hans Nygren 1,87 0,45 2022-12-28
Rolf Karlsson 1,82 0,44 2022-12-28
Försäkringsaktiebolaget Skandia 0,81 0,20 2022-12-28
Olle Jönsson 0,64 0,16 2022-12-28
Creative Invest One AB 0,36 0,09 2022-12-28
Handelsbanken Liv Försäkring AB 0,29 0,07 2022-12-28
Hazina Ljungman 0,27 0,21 2022-12-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-05-26 Delårsrapport 2023-Q3

  • 2023-08-28 Bokslutskommuniké 2023

  • 2023-11-17 Delårsrapport 2024-Q1

  • 2023-11-23 Årsstämma 2023